Cargando…

Therapeutic drug monitoring for biological medications in inflammatory bowel disease

Therapeutic drug monitoring (TDM) is the measurement of serum drug concentrations and anti-drug-antibodies (ADA) for biologic therapies used to treat inflammatory bowel disease (IBD). The aim of this article is to review the current literature concerning reactive and proactive TDM for both adults an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cogan, Rachel C., El-Matary, Basem W., El-Matary, Wael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752529/ https://www.ncbi.nlm.nih.gov/pubmed/35343213 http://dx.doi.org/10.4103/sjg.sjg_3_22

Ejemplares similares

Inflammatory Bowel Disease and the Environment: More to Come
por: El-Matary, Wael
Publicado: (2020)

Advances in Nutritional Management of Pediatric Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2021)

Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020)

Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2020)

Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease
por: Rempel, Julie, et al.
Publicado: (2021)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective
por: El-Matary, Wael, et al.
Publicado: (2018)

Immune-related disorders in families of children with inflammatory bowel disease - A prospective cohort study
por: Sibtain, Alyzée M, et al.
Publicado: (2011)

Histopathological changes in anatomical distribution of inflammatory bowel disease in children: a retrospective cohort study
por: Tsang, Jessica, et al.
Publicado: (2012)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

The Gluten-Free Diet for Celiac Disease and Beyond
por: Aljada, Bara, et al.
Publicado: (2021)

Are Patient Self-reported Healthcare Utilization Data Reliable in Persons With IBD?
por: El-Matary, Wael
Publicado: (2021)

Oral Bran in Patients With Quiescent Ulcerative Colitis: Another Piece in the Diet Puzzle
por: El-Matary, Wael
Publicado: (2020)

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Vaughn, Byron P.
Publicado: (2021)

Celiac Disease Presenting as Fever of Unknown Origin
por: Cooney, Megan J., et al.
Publicado: (2013)

A Case-Based Approach to New Directions in Dietary Therapy of Crohn’s Disease: Food for Thought
por: Levine, Arie, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

A171 INTESTINAL INTERFERON-LAMBDA RECEPTOR 1 EXPRESSION AND RESPONSES ARE SIGNIFICANTLY DECREASED IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Ogungbola, O, et al.
Publicado: (2023)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
por: Kapoor, Akshay, et al.
Publicado: (2021)

Colonic Abnormalities in Manitoban Children with Helicobacter pylori Gastritis
por: Banik, Upama, et al.
Publicado: (2018)

Celiac disease presenting as rickets in Saudi children
por: Assiri, Asaad, et al.
Publicado: (2013)

Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
por: Papamichael, Konstantinos, et al.
Publicado: (2023)

Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
por: Lee, Scott D., et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Prevalence of Gastroduodenal Polyps in Children With Familial Adenomatous Polyposis
por: Stone, James K, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
por: El-Matary, W, et al.
Publicado: (2022)

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
por: Ward, Mark G., et al.
Publicado: (2018)

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
por: Restellini, Sophie, et al.
Publicado: (2021)

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
por: Martins, Camilla de Almeida, et al.
Publicado: (2022)

The Association of Vitamin D Status with Disease Activity in a Cohort of Crohn’s Disease Patients in Canada
por: Alrefai, Dania, et al.
Publicado: (2017)

A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy
por: Patel, Sanket, et al.
Publicado: (2023)

Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network—A Joint Partnership of CIHR and the CH.I.L.D. Foundation
por: El-Matary, Wael, et al.
Publicado: (2017)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qfbrt01jbt1kelfmgp47kloofi